WHO ICTRP trial
The study of radiotherapy for gynecological tumors using lipiodol
JPRN-jRCTs021190022 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-jRCTs021190022 |
|---|---|
| Public title | The study of radiotherapy for gynecological tumors using lipiodol |
| Scientific title | Prospective study about the safety of radiotherapy for gynecologic tumors using ethyl ester of iodinated poppy-seed oil fatty acid - The study of radiotherapy for gynecological tumors using lipiodol |
| Primary sponsor | Umezawa Rei |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Conditions | Cervical cancer, Vaginal cancer Cervical cancer, Vaginal cancer;Cervical cancer, Vaginal cancer |
| Interventions | Injection of lipiodol at 2-3 mm under the submucosa at two or three point around the tumor.;Lipiodol |
| Registration date | Feb 20, 2020 |
| Target size | 50 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: